Latest Entitlement Offer News

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

Macarthur Minerals has relaunched a renounceable rights issue to raise nearly A$2 million, fully underwritten by Gold Valley, aiming to fund its Lake Giles Iron Project and strengthen its balance sheet.

Macarthur Minerals Limited has issued a replacement prospectus for a renounceable entitlement offer aiming to raise approximately AUD 2 million, fully underwritten by Gold Valley Yilgarn Pty Ltd. The offer includes free attaching options and supports the company’s exploration and operational funding needs.

Metgasco Ltd has successfully raised approximately $750,000 through a partially underwritten entitlement offer to fund a production uplift program targeting its Odin and Vali gas fields in the Cooper Eromanga Basin.

Alvo Minerals Limited has had its trading suspension lifted immediately following the release of details about its Entitlement Offer, signaling renewed market activity.

North Stawell Minerals Ltd (ASX, NSM) is advancing its gold exploration ambitions with a $3.6 million equity raising aimed at funding key projects near the prolific Stawell Gold Mine in Victoria. The capital injection will support drilling and geological modelling to unlock new gold discoveries under a thin sediment cover.

North Stawell Minerals has announced a combined $3.6 million capital raise through a placement and a pro-rata entitlement offer, aiming to bolster its exploration activities without materially altering company control.

North Stawell Minerals has launched a $3.6 million equity raising, anchored by a cornerstone investor, to fund exploration at key Victorian gold projects and sustain operational momentum through 2025.

Patrys Limited has raised $358,362 through a share placement and announced significant board changes, including the appointment of Dr Anton Uvarov and Mr Peter Christie, alongside making the CEO role redundant.

Tempest Minerals has completed a pro-rata entitlement offer, raising over $600,000 to fund exploration in Western Australia, though a significant shortfall remains to be allocated.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Prodigy Gold NL has announced a non-renounceable entitlement offer aiming to raise approximately $6.35 million to fund exploration and development across its key gold projects in the Tanami region. The offer is partially underwritten, providing a degree of funding certainty amid ongoing market and operational risks.